Tasneem Dohadwala, MBA

Tasneem Dohadwala is the Founding Partner of Excelestar Ventures, where she and her team are active investors in founders that exhibit compelling promise in medical technology, deep technology and beyond. Previously, her experience included working in financial services on the sell-side at Lehman Brothers and Matrix Partners. Notable investments during her time at Excelestar Ventures include Augmenix (acq. by Boston Scientific), nVision (acq. by Boston Scientific), Altiostar Networks (acq. by Rakuten),  Conformal Medical, Instylla, Brixton Biosciences and Terecircuits.

At her helm, Excelestar Ventures has been named one of the top 100 Women-Led Businesses in Massachusetts by The Boston Globe. Tasneem is a graduate of Wellesley College and Harvard Business School.

Sanjay Mahanti

Sanjit Mahanti leads Akido’s business development team focused on the expansion of the Akido Care medical network. Sanjit has over 15 years of technology and innovation experience in the healthcare space and has held executive leadership positions across the academic healthcare, population management and technology sectors. During his tenure as Chief Business Development Officer for Keck Medicine of USC, he was instrumental in the creation of the organization’s innovation management function.

Sanjit loves to spend his time cooking and traveling. He is an active member of his community serving as a board member for Adventist Health Glendale and as the team manager for his son’s youth soccer team.

Delia Silva, PhD

Delia Silva is a Managing Director and Partner in L.E.K. Consulting’s Boston office. She joined the firm in 2014 and specializes in the life sciences and pharmaceutical sector, with a focus on growth strategy and organization and performance, both in the U.S. and globally. Delia has extensive experience across a number of therapeutic areas and product modalities, including neuroscience, rare disease and infectious disease. She has helped clients, from clinical-stage biotechs to big pharma, through organizational scale-ups and design, launch planning, portfolio growth strategy, market entry assessments, due diligence, commercial strategy, and go-to-market modeling.

Delia holds a Ph.D. in neuroscience from Johns Hopkins School of Medicine and a B.S. in chemistry from Boston University.

Kanishk Tantia

Kanishk is a panel director for the HBS Healthcare Conference, and an RC year student at HBS. He has spent six years working as an AI engineer with Microsoft, collaborating with Microsoft’s key healthcare clients including Siemens Digital Health and Humana on enterprise software architecture and solution design. He is also passionate about AI equity and access in healthcare, and about ensuring that technological tools are used safely, effectively, and ethically.